BD
Broadrick Dale Dirigeant
Other M
US US · SEC (Form 4)
€265,700
▲ Purchases (14 ops.)
Explore the full record of transactions filed by Broadrick Dale, Dirigeant. Officer active across 1 companies, notably BioRestorative Therapies, Inc.. Cumulatively, 14 reports have been published. Total volume traded: €266k. The latest transaction was disclosed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations 14 total
€2,164 600 shares @ €3.6061 0.044% mcap 0.8% of flow
Common Stock
SEC:0001567619-22-013309:0 · 17 Jun 2022
Ideal exit: 14 Mar 2023 (T+270) €4,269 1,200 shares @ €3.5576 0.087% mcap 1.6% of flow
Common Stock
SEC:0001567619-22-013111:0 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) €4,893 1,300 shares @ €3.7641 0.100% mcap 1.8% of flow
Common Stock
SEC:0001567619-22-012901:0 · 13 Jun 2022
Ideal exit: 10 Mar 2023 (T+270) €4,017 1,000 shares @ €4.017 0.082% mcap 1.5% of flow
Common Stock
SEC:0001567619-22-012747:0 · 9 Jun 2022
Ideal exit: 6 Mar 2023 (T+270) €15,893 3,600 shares @ €4.4147 0.32% mcap 6.0% of flow
Common Stock
SEC:0001567619-22-012605:0 · 7 Jun 2022
Ideal exit: 4 Mar 2023 (T+270) €5,469 1,200 shares @ €4.5571 0.11% mcap 2.1% of flow
Common Stock
SEC:0001567619-22-012430:0 · 3 Jun 2022
Ideal exit: 28 Feb 2023 (T+270) €4,360 1,000 shares @ €4.3603 0.089% mcap 1.6% of flow
Common Stock
SEC:0001567619-22-012367:0 · 2 Jun 2022
Ideal exit: 27 Feb 2023 (T+270) €38,597 9,213 shares @ €4.1894 0.79% mcap 14.5% of flow
Common Stock
SEC:0001567619-22-012250:0 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) €36,888 10,957 shares @ €3.3666 0.75% mcap 13.9% of flow
Common Stock
SEC:0001567619-22-012010:0 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) €16,178 4,950 shares @ €3.2683 0.33% mcap 6.1% of flow
Common Stock
SEC:0001567619-22-011949:0 · 26 May 2022
Ideal exit: 20 Feb 2023 (T+270) €12,984 2,500 shares @ €5.1935 0.27% mcap 4.9% of flow
Common Stock
SEC:0001567619-22-008301:0 · 6 Apr 2022
Ideal exit: 1 Jan 2023 (T+270) €85,674 16,000 shares @ €5.3546 1.75% mcap 32.2% of flow
Common Stock
SEC:0001567619-22-008245:0 · 5 Apr 2022
Ideal exit: 31 Dec 2022 (T+270) €23,081 5,000 shares @ €4.6161 0.47% mcap 8.7% of flow
Common Stock
SEC:0001567619-22-007864:0 · 29 Mar 2022
Ideal exit: 24 Dec 2022 (T+270) €11,233 2,270 shares @ €4.9483 0.23% mcap 4.2% of flow
Common Stock
SEC:0001567619-22-007664:0 · 1 Mar 2022
Ideal exit: 26 Nov 2022 (T+270) About Broadrick Dale Broadrick Dale is an executive at BioRestorative Therapies, Inc. He plays a key role in the management and direction of the company, contributing to the implementation of strategies aimed at achieving organizational goals. His experience in the biological therapies sector is an asset for the company.